Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer
European Urology - Netherlands
doi 10.1016/j.eururo.2016.02.055
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2016
Authors
Publisher
Elsevier BV